ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

OGN Organon and Co

20.42
0.81 (4.13%)
Última actualización: 13:15:20
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Organon and Co OGN NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.81 4.13% 20.42 13:15:20
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
19.75 19.59 20.43 19.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:30BWOrganon Reports Results for the First Quarter Ended March..
09/4/202407:13BWProlia ® とXgeva ®..
08/4/202413:31BWL'essai clinique comparatif de phase 3 du candidat..
08/4/202405:15BWOrganon To Report First Quarter 2024 Results and Host..
08/4/202405:00BWPhase 3 Comparative Clinical Study of Prolia® and Xgeva®..
08/3/202408:01PRNCAOn International Women's Day, Organon Canada is encouraging..
01/3/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202407:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202410:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202407:00BWOrganon Announces HADLIMA™ (adalimumab-bwwd) Has Been..
15/2/202406:48EDGAR2Form 8-K - Current report
15/2/202406:30BWOrganon Reports Results for the Fourth Quarter and Full Year..
13/2/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202406:30BWOrganon To Report Fourth Quarter and Full Year Results and..
10/1/202406:33BWOrganon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2%..
08/1/202406:30BWOrganon affirms 2023 revenue and Adjusted EBITDA guidance..
21/12/202306:30BWOrganon To Present at the 42nd Annual J.P. Morgan Healthcare..
19/12/202307:30BWOrganon et Lilly concluent un accord de commercialisation en..
19/12/202303:11BWOrganon と Lilly、ヨーロッパで 2 種類の片頭痛薬商業化契約を締結
18/12/202320:26BWOrganon und Lilly schließen Vermarktungsvereinbarung für..
18/12/202306:30BWOrganon & Lilly Enter Commercialization Agreement in Europe..
05/12/202315:31EDGAR2Form 8-K - Current report
21/11/202306:30BWOrganon To Present at the Piper Sandler 35th Annual..
07/11/202315:15GLOBESamsung Bioepis & Organon Announce FDA Acceptance of..
03/11/202306:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202306:38EDGAR2Form 8-K - Current report
02/11/202306:30BWOrganon Reports Results for the Third Quarter Ended..
01/11/202306:30BWOrganon and Sempre Health Announce Collaboration on New..
26/10/202306:00PRNCAOrganon Canada annonce la disponibilité d'une préparation..
19/10/202306:30BWOrganon To Report Third Quarter Results and Host Conference..
13/10/202317:02PRNUSLululemon Athletica & Hubbell Set to Join S&P 500; Others to..
27/9/202314:13BWOrganon figure sur la liste « Change the World » de Fortune..
27/9/202312:43BWオルガノン、フォーチュン誌の2023年チェンジ・ザ・ワールドリストで避妊の選択肢へのアクセスを拡大するリーダーシップで表彰される
27/9/202312:33BWOrganon auf der Fortune „Change the World“-Liste 2023 für..
27/9/202306:30BWOrganon Recognized on Fortune’s 2023 Change the World List..
26/9/202306:01PRNCAOn World Contraception Day, Organon Canada Declares Support..
14/9/202316:12BWFirst Real-World Observational Study of the JADA® System, a..
05/9/202318:38BWオルガノン、2人のリーダー任命で研究開発の専門知識を強化
05/9/202315:27BWOrganon renforce ses capacités de recherche et de..
05/9/202312:52BWOrganon stärkt Forschungs- und Entwicklungskompetenz mit..
05/9/202309:00BWOrganon Bolsters Research & Development Expertise with Two..
09/8/202307:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:58EDGAR2Form 8-K - Current report
08/8/202306:30BWOrganon Reports Results for the Second Quarter Ended June..
01/8/202306:00GLOBESamsung Bioepis & Organon Announce Topline Results from..
17/7/202306:30BWOrganon To Report Second Quarter Results and Host Conference..
07/7/202315:05EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock